Group 1 - The company plans to issue A-shares to specific investors, with a maximum of 211,792,834 shares, which is 30% of the total shares before the issuance [1][4][51] - The total amount to be raised from this issuance is not to exceed 300 million yuan [1][4][59] - The issuance is expected to dilute the immediate returns, affecting key financial metrics such as earnings per share and return on equity in the short term [1][4][9] Group 2 - The company has conducted a thorough analysis of the impact of this issuance on its financial indicators and has proposed measures to mitigate the dilution of immediate returns [1][4][9] - The assumptions for the financial impact analysis include stable macroeconomic conditions and the completion of the issuance by June 2026 [2][3] - The company anticipates that the economic benefits from the raised funds will take time to materialize, leading to a temporary decrease in earnings per share [4][5] Group 3 - The funds raised will be used for projects closely aligned with the company's main business, enhancing its competitive edge and supporting long-term growth [5][6][11] - The company has a strong team and technical reserves to support the implementation of the fundraising projects [7][8] - The company will ensure effective management of the raised funds, adhering to regulations and monitoring their usage [10][12] Group 4 - The company commits to maintaining a fair profit distribution system and enhancing investor return mechanisms post-issuance [13] - The board and senior management have made commitments to ensure the fulfillment of measures to compensate for the dilution of immediate returns [14][15] - The company will hold a temporary shareholders' meeting on October 15, 2025, to discuss the issuance [16][17][18]

Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]

Joint Ventures and Investments - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds a 51% stake [3] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao Biological Materials Co., a high-tech enterprise focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Cloning's equity to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Corporate Actions - New Sai Co. announced the resignation of its director and general manager, Chen Jianjiang, due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [8] - Zhejiang University Network New plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] Contracts and Orders - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase the company's profit by approximately 62.86 million yuan in 2025 [12] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [13] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for high-voltage energy storage systems [14] - ST Songfa's subsidiary signed contracts for the construction of four oil tankers, with a total contract value between 400 million to 600 million USD [15] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [16] Regulatory and Compliance - Jingliang Holdings received an administrative regulatory decision from Hainan Securities Regulatory Bureau for violations related to trade activities, involving an income amount of 299 million yuan [18] Shareholder Actions - Zaiseng Technology's controlling shareholder plans to reduce its stake by up to 3%, amounting to approximately 30.9 million shares [20] - Compton plans to reduce its repurchased shares by up to 1%, totaling approximately 2.5644 million shares [21] Financing Activities - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase from Industrial and Commercial Bank of China [23] - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [25]

Group 1 - The company Xianhe Co., Ltd. (603733.SH) announced a plan to issue A-shares to specific investors, aiming to raise a total of no more than 3 billion yuan (including the amount) [1] - The net proceeds from this fundraising, after deducting issuance costs, will be used for the second phase of the high-performance paper-based new materials project in Sanjiangkou New District, Guangxi, as well as to supplement working capital [1]

Group 1 - The company, Xianhe Co., Ltd. (stock code: 603733), announced on September 26 that it plans to issue A-shares to specific investors [1] - The fundraising target is up to 3 billion yuan, which will be used for the second phase of the high-performance paper-based new materials project in Sanjiangkou New District, Guangxi, and to supplement working capital [1]

Group 1 - The company Xianhe Co., Ltd. (603733.SH) announced a plan to issue A-shares to specific investors, with a total fundraising amount not exceeding 3 billion RMB [1] - The issuance will involve no more than 211,792,834 shares, targeting up to 35 specific investors [1] - The raised funds will be used for the second phase of the high-performance paper-based new material project in the Sanjiangkou New District of Guangxi and to supplement working capital [1]

Group 1 - The company plans to issue A-shares with a par value of 1 yuan per share, with a maximum issuance of 211,792,834 shares [1] - The fundraising target is up to 3 billion yuan, which will be used for the second phase of the high-performance paper-based new materials project in Guangxi Sanjiangkou New Area and to supplement working capital [1]

截至发稿，仙鹤股份市值为166亿元。 每经头条（nbdtoutiao）——5年增长33倍，这类新险种卖爆了，身边很多人都需要，30多家险企蜂拥而 入⋯⋯ （记者 王晓波） 每经AI快讯，仙鹤股份（SH 603733，收盘价：23.55元）9月26日晚间发布公告称，本次向特定对象发 行的方案及相关事项已经2025年9月26日召开的公司第四届董事会第三次会议审议通过。本次向特定对 象发行A股股票的发行对象为不超过35名特定投资者（含本数），其中，本次发行的股票数量按照募集 资金总额除以发行价格确定，同时本次发行股票数量不超过本次向特定对象发行前公司总股本1的 30%，即本次发行不超过约2.12亿股，最终发行数量上限以中国证监会同意注册的发行数量上限为准。 发行价格不低于定价基准日前20个交易日公司股票交易均价的80%。本次发行拟募集不超过30亿元，募 集资金用于以下用途：广西三江口新区高性能纸基新材料项目二期工程项目，总投资约54.04亿元，拟 投入募集资金21亿元；补充流动资金项目，总投资9亿元，拟投入募集资金9亿元。 2024年1至12月份，仙鹤股份的营业收入构成为：造纸行业占比96.05%，其他业务占比3. ...

证券代码：603733 证券简称：仙鹤股份 债券代码：113632 债券简称：鹤 21 转债 仙鹤股份有限公司 （浙江省衢州市衢江区天湖南路 69 号） 向特定对象发行 A 股股票预案 二〇二五年九月 4、投资者如有任何疑问，应咨询自己的股票经纪人、律师、专业会计师或 其他专业顾问。 5、本预案所述事项并不代表审批机关对于本次向特定对象发行 A 股股票相 关事项的实质性判断、确认、批准或同意注册。本预案所述本次向特定对象发行 A 股股票相关事项的生效和完成尚需公司股东会审议通过，并需取得上海证券交 易所审核通过并取得中国证券监督管理委员会同意注册的批复。 1 仙鹤股份有限公司 向特定对象发行 A 股股票预案 特别提示 仙鹤股份有限公司 向特定对象发行 A 股股票预案 公司声明 1、公司及董事会全体成员保证本预案内容真实、准确、完整，并确认不存 在虚假记载、误导性陈述或重大遗漏。 2、本次向特定对象发行 A 股股票完成后，公司经营与收益的变化，由公司 自行负责；因本次向特定对象发行 A 股股票引致的投资风险，由投资者自行负 责。 3、本预案是公司董事会对本次向特定对象发行 A 股股票的说明，任何与之 相反的声明 ...